Supriya Lifescience Ltd (SUPRIYA) — Announcement | 2 September 2026
Supriya Lifescience disclosed that the legal case involving its General Manager of Sales & Marketing remains sub judice with no new court orders as of September 2, 2025, following prior updates shared in August 2026 earnings call transcripts.
About Supriya Lifescience Ltd (SUPRIYA)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when SUPRIYA files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track SUPRIYA — Free💡 Ask AI about this filing
📊 More SUPRIYA filings
- Announcement — 28 September 2026Supriya Lifescience Ltd announced that its trading window will close on October 1, 2026, and remain ...
- 🟡 Voting Results — 25 September 2026Supriya Lifescience held its 18th Annual General Meeting on September 24, 2026, via video conference...
- 🔴 Announcement — 23 September 2026Supriya Lifescience announced that the Bombay High Court allowed provisional release of 200 kg of ke...
- 🔴 Announcement — 20 September 2026Supriya Lifescience announced a virtual analyst meeting on September 25, 2026, from 11:00 AM to 12:0...
- 🔴 Announcement — 11 September 2026Supriya Lifescience announced a virtual analyst/investor meeting on September 17, 2026, from 11:00 A...
🔥 Also filed on 2 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when SUPRIYA files new disclosures
Track SUPRIYA filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track SUPRIYA — FreeFree account · 2 AI queries/day